INTIMAL THICKENING & ANTITOXIDANTS IN HISPANICS & ANGLOS

内膜增厚

基本信息

  • 批准号:
    6530663
  • 负责人:
  • 金额:
    $ 80.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1994
  • 资助国家:
    美国
  • 起止时间:
    1994-01-01 至 2004-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Adapted from Investigator's Abstract) Cardiovascular diseases remain the major causes of disability and early death in the U.S., and improved treatment and prevention will stem from knowledge of the etiology of atherosclerosis (Ath). The Los Angeles Atherosclerosis Study (LAAS) is a longitudinal investigation of the etiology of Ath focusing on diet and oxidative mechanisms in a randomly selected cohort of 573 utility workers, with oversampling of Hispanics. Preliminary results include a protective relation between plasma oxygenated carotenoids and 1.3 year change in the intima-media thickness (IMT) of the common carotid arteries, causal interpretation of which is supported by the findings that lutein inhibits monocyte attraction by LDL oxidized in a model of the artery wall, and that lutein supplementation reduced atherosclerosis extent by 86 percent in apo E null mice. Also, higher intake of vitamin C from supplements was significantly associated with increased progression of carotid IMT. In contrast, higher intake of vitamin C from food was associated with reduced progression of carotid IMT, but this protective relation was not significant. The protective relation of HDL-C with IMT was enhanced by higher plasma, beta-cryptoxanthin and by increased plasma level of an enzyme (paraoxonase, PON) that destroys oxidized lipids. This application proposes continued observation of the LAAS cohort with the addition of two ultrasound measures of arterial dysfunction and the investigation of new etiologic factors for Ath suggested by laboratory findings of collaborators. Additional observations will also increase power for detecting relations with IMT. The new risk factors focus on pathways that promote or inhibit LDL damage and inflammatory responses in the artery wall. The new measures of arterial function and dysfunction are (1) endothelial function of the brachial artery (lumen diameter increase in response to hyperemia); and (2) distensibility or stiffness of the common carotid artery. These additional measures, together with those in the original protocol, will allow investigation of relations between longitudinal change in Ath and dietary antioxidants, antioxidant enzymes, and genetic polymorphisms.
描述:(改编自研究者摘要)心血管疾病 仍然是美国残疾和早逝的主要原因,和改进 治疗和预防将源于对病原学的了解, 动脉粥样硬化(Ath)。洛杉矶动脉粥样硬化研究(LAAS)是一项 Ath病因的纵向调查,重点是饮食和 在随机选择的573名公用事业工人的队列中, 西班牙裔的过度抽样初步结果包括保护关系 血浆含氧类胡萝卜素与内膜中层1.3年变化之间的关系 颈总动脉内膜中层厚度(IMT),其因果关系解释 叶黄素抑制低密度脂蛋白对单核细胞的吸引, 在动脉壁模型中氧化,并且叶黄素补充减少了 动脉粥样硬化程度降低86%。此外, 补充剂中的维生素C与 颈动脉IMT进展。相反,从食物中摄入更多的维生素C 与颈动脉IMT进展减缓相关,但这种保护性 相关性不显著。HDL-C与IMT的保护关系 通过更高的血浆β-隐黄素和通过增加的血浆β-隐黄素水平来增强 一种破坏氧化脂质的酶(对氧磷酶)。 本申请建议继续观察LAAS队列, 增加了两种动脉功能障碍的超声测量方法, 实验室检查提示哮喘新病因探讨 的合作者。额外的观察也将增加 检测与IMT的关系。新的风险因素集中在以下途径, 促进或抑制动脉壁中的LDL损伤和炎症反应。 动脉功能和功能障碍的新措施是(1)内皮 肱动脉功能(管腔直径增加, 充血);和(2)颈总动脉的扩张性或僵硬。 这些补充措施连同原议定书中的措施将 允许研究Ath的纵向变化与饮食 抗氧化剂、抗氧化酶和遗传多态性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES H DWYER其他文献

JAMES H DWYER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES H DWYER', 18)}}的其他基金

ANTIOXIDANTS AND PREVENTION OF EARLY ATHEROSCLEROSIS
抗氧化剂和预防早期动脉粥样硬化
  • 批准号:
    2029092
  • 财政年份:
    1995
  • 资助金额:
    $ 80.09万
  • 项目类别:
ANTIOXIDANTS AND PREVENTION OF EARLY ATHEROSCLEROSIS
抗氧化剂和预防早期动脉粥样硬化
  • 批准号:
    2430737
  • 财政年份:
    1995
  • 资助金额:
    $ 80.09万
  • 项目类别:
ANTIOXIDANTS AND PREVENTION OF EARLY ATHEROSCLEROSIS
抗氧化剂和预防早期动脉粥样硬化
  • 批准号:
    2437664
  • 财政年份:
    1995
  • 资助金额:
    $ 80.09万
  • 项目类别:
ANTIOXIDANTS AND PREVENTION OF EARLY ATHEROSCLEROSIS
抗氧化剂和预防早期动脉粥样硬化
  • 批准号:
    2229214
  • 财政年份:
    1995
  • 资助金额:
    $ 80.09万
  • 项目类别:
INTIMAL THICKENING & ANTIOXIDANTS IN HISPANICS & ANGLOS
内膜增厚
  • 批准号:
    2225950
  • 财政年份:
    1994
  • 资助金额:
    $ 80.09万
  • 项目类别:
INTIMAL THICKENING & ANTIOXIDANTS IN HISPANICS & ANGLOS
内膜增厚
  • 批准号:
    2637997
  • 财政年份:
    1994
  • 资助金额:
    $ 80.09万
  • 项目类别:
INTIMAL THICKENING & ANTIOXIDANTS IN HISPANICS & ANGLOS
内膜增厚
  • 批准号:
    837161
  • 财政年份:
    1994
  • 资助金额:
    $ 80.09万
  • 项目类别:
INTIMAL THICKENING & ANTIOXIDANTS IN HISPANICS & ANGLOS
内膜增厚
  • 批准号:
    2028872
  • 财政年份:
    1994
  • 资助金额:
    $ 80.09万
  • 项目类别:
INTIMAL THICKENING & ANTIOXIDANTS IN HISPANICS & ANGLOS
内膜增厚
  • 批准号:
    2225953
  • 财政年份:
    1994
  • 资助金额:
    $ 80.09万
  • 项目类别:
INTIMAL THICKENING & ANTITOXIDANTS IN HISPANICS & ANGLOS
内膜增厚
  • 批准号:
    6637470
  • 财政年份:
    1994
  • 资助金额:
    $ 80.09万
  • 项目类别:

相似海外基金

Enhancing gamete cryoprotective properties of graphene oxide by dual functionalization with antioxidants and non-penetrating cryoprotectant molecules
通过抗氧化剂和非渗透性冷冻保护剂分子的双重功能化增强氧化石墨烯的配子冷冻保护特性
  • 批准号:
    24K18002
  • 财政年份:
    2024
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Sustainable antioxidants for industrial process fluids
SBIR 第一阶段:工业过程流体的可持续抗氧化剂
  • 批准号:
    2222215
  • 财政年份:
    2023
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Standard Grant
Development of a new bone augmentation method that enables long-term survival and long-term functional expression of transplanted cells by antioxidants
开发一种新的骨增强方法,通过抗氧化剂使移植细胞能够长期存活和长期功能表达
  • 批准号:
    23K09272
  • 财政年份:
    2023
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Non-Invasive Probing Cellular Oxidative Stress and Antioxidants Therapeutic Effectiveness
非侵入性探测细胞氧化应激和抗氧化剂的治疗效果
  • 批准号:
    10652764
  • 财政年份:
    2023
  • 资助金额:
    $ 80.09万
  • 项目类别:
Mitochondria-targeting Novel Cationic Hydrazone Antioxidants for the Treatment of Preeclampsia
线粒体靶向新型阳离子腙抗氧化剂用于治疗先兆子痫
  • 批准号:
    10730652
  • 财政年份:
    2023
  • 资助金额:
    $ 80.09万
  • 项目类别:
Latent Antioxidants for Environmentally Responsible Polymer Formulations
用于环保聚合物配方的潜在抗氧化剂
  • 批准号:
    RGPIN-2018-04107
  • 财政年份:
    2022
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Discovery Grants Program - Individual
Contribution of antioxidants to regeneration of rotator cuff insertion
抗氧化剂对肩袖插入再生的贡献
  • 批准号:
    22K16720
  • 财政年份:
    2022
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of different doses of antioxidants(Vitamin E) intake on exercise induced oxidative stress, antioxidative capacity and chronic inflammation
不同剂量抗氧化剂(维生素E)摄入对运动引起的氧化应激、抗氧化能力和慢性炎症的影响
  • 批准号:
    22K11609
  • 财政年份:
    2022
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Polyunsaturated fatty acid (PUFA), inflammation and antioxidants
多不饱和脂肪酸 (PUFA)、炎症和抗氧化剂
  • 批准号:
    RGPIN-2019-05674
  • 财政年份:
    2022
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Discovery Grants Program - Individual
Suppressed methemoglobin formation of artificial red cell by liposomal antioxidants and its mechanism.
脂质体抗氧化剂抑制人工红细胞高铁血红蛋白形成及其机制
  • 批准号:
    22K12824
  • 财政年份:
    2022
  • 资助金额:
    $ 80.09万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了